Elkind-Hirsch KE, Chappell N, Shaler D, Storment J, Bellanger D (2022) Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study
With the same dosage and price, it delivers effects that can last up to 20 times longer than traditional injections
As more employers bring SmartRx to their people, we expect the impact to scale significantly by reducing drug costs and building the clinical foundation that makes savings and outcomes stick
Actual timelines may differ
Step 3: Inject on the new day
Understanding potential errors in patch application is essential for optimising therapeutic outcomes and minimising adverse effects